Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

French team synthesizes novel ALK tyrosine kinase receptor inhibitors

Nov. 13, 2012

Nerviano Medical Sciences patents novel protein kinase inhibitors

Nov. 13, 2012

Negative findings reported from LEAP study of CO-101

Nov. 13, 2012

Pivotal HEAT Study of ThermoDox in primary liver cancer reaches target for unblinding

Nov. 12, 2012

Daiichi Sankyo submits supplemental NDA for Topotecin in Japan

Nov. 12, 2012

VS-5584 treatment inhibits cancer stem cells in vitro and in vivo

Nov. 12, 2012

U.S. team prepares novel MAbs for cancer

Nov. 12, 2012

Scientists at Vertex Pharmaceuticals patent new protein kinase inhibitors

Nov. 9, 2012

Nektar Therapeutics synthesizes promising thymidylate synthase inhibitor

Nov. 9, 2012

Sloan-Kettering Institute for Cancer Research patents new HSP 90 inhibitors

Nov. 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...